News & Events

When Opportunity Knocks, You Answer | Helen Austen

Have you ever been at the right place at just the right time? Sometimes opportunity finds us when we’re looking, other times we’re caught by surprise. When opportunity knocked for Helen Austen, she answered. And she hasn’t looked back a day since. Summed up, Helen would tell you that the opportunity to work with Tanner…

When Devotion Meets Work | Carolina Cortez

In the bundle of positive vibes and laughs that Carolina Cortez brings to work, she also carries with her an unbridled sense of devotion. She remembers a day back when Tanner Pharma Group was in its infancy, Banks said to her about the company, “This is your baby, and if it grows, you grow as…

A Family Man, at Work and at Home | Bill Taylor

There’s a certain joy you feel as you watch your family grow in number. There’s a similar feeling when your company does the same, especially when you can call them family. Without a doubt, William Taylor, known as Bill around the office, is one of the longest standing members of Tanner Pharma Group. He’s General…

Started Small, Ended Big | Gaby Bedoya

She started small, and today looks back with gratitude because of where she is now.  For a little over eight years, Gaby Bedoya has been serving under different roles at Tanner Pharma Group. First as a quoter, today as a Business Development Manager for TannerGAP (Global Access Programs), and more recently the driving force behind…

Managed access programs explained with TannerMAP

Tanner’s Managed Access Program (MAP) division specializes in increasing access to life-saving treatments for patients who would otherwise be unable to access them, either via pre-approval access programs or global donation programs. TannerMAP also develops and delivers access programs for specific medicines from manufacturer partners. TannerMAP focuses on providing access to medicines that are commercialized…

Crisis response: meeting urgent demand for PPE and tests in the pandemic

As Covid-19 swept across the world, Tanner Pharma Group started receiving near-insurmountable requests from multiple industries for testing kits and PPE. Learn more about how Tanner met demand through the development of a dedicated subdivision, TannerGMS, and learn what the future holds for diagnostics and PPE as we emerge from the shadow of the Covid-19.…

Partnering to Respond to a Possible Nuclear Threat

Originally posted on May 25, 2022 on PharmaceuticalExecutive.com. Steve Scalia, Bob Mulroy, John L. McManus Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity. In early March, an explosion at Ukraine’s Zaporizhzhia nuclear power plant after intense Russian shelling had the world…

Birmingham Biotech and Tanner Pharma Group Enter Distribution Partnership for Innovative Nasal Spray in Latin America

Birmingham, UK, 31st May 2022 / Sciad Newswire / Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and TannerLAC UK Limited (“TannerLAC”), a part of Tanner Pharma Group, have entered into a license agreement for the distribution of Norizite™ Nasal Spray in Latin America. TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner…

Tanner Pharma Expands Operations to Ireland

Tanner Pharma announced today its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team. With the withdrawal of the United Kingdom from the European Union, it was essential for Tanner to maintain a presence in…

Charlotte Company Stockpiling Drug in Europe to Treat Radiation and Chemical Exposure

The move was made due to Russia’s invasion of Ukraine and the escalating potential for incidents that would require the medication. Originally posted on WCNC.com. Author: Curtis Carden | Published: 9:25 PM EDT April 4, 2022 | Updated: 11:27 PM EDT April 4, 2022 CHARLOTTE, N.C. — An international distributor of medicines, based in Charlotte, is upping its…

Q1 2022 Global Team Event!

Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine

Leukine is FDA Approved to Treat Acute Radiation Syndrome (ARS) and Recommended in EMEA/CPMP Guidance to Treat Systemic Sulfur Mustard (HD) Gas Exposure LONDON–(BUSINESS WIRE)–Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in Europe. This action is being…

Tanner Pharma Featured in the EDPNC’s 2021 Annual Report as Top Global Reach Exporter

Read original publication on the EDPNC website. TRADE TEAM HELPS COMPANY IMPROVE GLOBAL ACCESS TO MEDICINES Headquartered in Charlotte, Tanner Pharma Group is a rapidly growing company with local roots and a global mission — to improve lives by increasing access to medicine around the world. Tanner teams up with U.S. pharmaceutical, biotech and health…

Early access programs: how real-world data capture helps regulatory approval

While clinical trials can prove that a medical product is safe and effective in a controlled environment, the vital data for how a new medicine will perform in the real world is often lacking. Learn more about the connection between real-world data capture and early access programs, and the role this plays in the approval…

Global access programs: meeting urgent medical needs

The mission of Tanner’s global access programs (GAP) division is to meet immediate medical needs for patients regardless of their geographical location. The division’s work includes addressing medicine market withdrawal, post-clinical trial solutions, mitigating drug shortages and managing medicine supply on a Named Patient basis. To learn more, we speak to Maryori Alvarenga, EVP of…

The benefits of early access programs

Patients living with critical illnesses may require access to medicines that are unavailable to them for various reasons. Life-changing treatments might take years to pass the necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through the creation and implementation of early access programs. These programs are compliant…

Minimizing disruption to the pharma supply chain

Just-in-time deliveries are of paramount importance in the pharmaceutical industry. While the global pandemic has caused significant disruption to the supply chain, it is still possible to maintain a robust and reliable delivery network to minimize delays in shipments. We learn how Tanner Pharma Group has successfully maneuvered supply chain challenges during the Covid-19 pandemic.…

Increasing the availability of medical products in Latin America

The availability of pharmaceuticals can be limited in certain emerging markets around the world. Latin America is one such region, where regulatory, political, and economic obstacles can present challenges with commercial launch and supply. As one of Tanner’s first divisions, TannerLAC was established to address these issues and ensure that supplies reach patients in the…